阿迪普辛是一种阿迪波金,可以改善糖尿病患者的β细胞功能
James C Lo1, Sanda Ljubicic2, Barbara Leibiger3
1Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Cell
|July 5, 2014
概括
脂肪组织蛋白质阿迪普辛对胰腺β细胞功能在2型糖尿病中至关重要. 恢复素水平可以改善胰岛素分泌和葡萄糖控制,从而提供一种潜在的新疗法.
科学领域:
- 代谢性疾病研究研究.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 2型糖尿病 (T2DM) 的特征是胰腺β细胞衰竭,导致胰岛素缺乏和高血糖.
- 脂肪组织中的信号分子阿迪波金在调节β细胞功能的作用是一个正在积极研究的领域.
研究的目的:
- 调查阿迪波金阿迪普辛在维持胰腺β细胞功能的作用及其作为T2DM治疗点的潜力.
主要方法:
- 利用缺乏素的转基因动物模型来评估葡萄糖代谢和胰岛素分泌.
- 用隔离的胰岛岛来研究葡萄糖刺激的胰岛素分泌.
- 给糖尿病小鼠服用阿迪普辛,以评估其对高血糖的影响.
- 鉴定和描述了素的下游信号通路,包括C3a及其受体.
主要成果:
- 缺乏素的小鼠表现出葡萄糖不耐受性和胰岛素分泌量减少.
- 在糖尿病小鼠中补充阿迪普辛,通过增强胰岛素分泌改善了高血糖症.
- 由素产生的C3a被确定为一种强大的胰岛素分泌剂.
- 发现C3a受体对于阿迪普辛对小岛的有益作用至关重要,通过增加ATP,呼吸和Ca2+水平来调解.
- 患有β细胞衰竭的2型糖尿病患者的阿迪普辛水平降低.
结论:
- 素/C3a信号通路代表脂肪组织和胰腺β细胞功能之间的关键联系.
- 这一途径在维护β细胞生理学方面起着有益的作用.
- 向素/C3a通路为治疗2型糖尿病提供了一个有希望的治疗策略.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Type II Diabetes II: Pathophysiology
19
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
19
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Hormones Regulating Blood Glucose
7.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
Insulin: The Receptor and Signaling Pathways
5.9K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K


